| (CCTG) HN.9/LA-OSCC | Randomized Phase II Study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Adjuvant Durvalumab versus Durvalumab plus Radiotherapy followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC) | Meyers, Dr Brandon | Open to recruitment | NCT03410615 |
| (LHRI) RADIO/Cisplatin Hearing Loss/Cisplatin HD vs LD | Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity in the treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) undergoing curative concurrent chemoradiotherapy (RADIO) | Meyers, Dr Brandon | Open to recruitment | NCT03649048 |
| (Galera) GTI-4419-301 / ROMAN | ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer | Meyers, Dr Brandon | Suspended/On hold | NCT03689712 |
Find a Trial
Contact Us